SynthesisFrontiers in oncology2021

BRCA1 Versus BRCA2 and PARP Inhibitors Efficacy in Solid Tumors:A Meta-Analysis of Randomized Controlled Trials.

Shan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.